Md. biotech outlines path for blood cancer drug, including in China

Washington Business Journal

Jan 6, 2020

Rockville biotech GlycoMimetics Inc. has entered into a license agreement worth $189 million or more with a West Coast company. The deal gives cancer therapy biopharma Apollomics I…